Literature DB >> 20339107

Globin phenotype of erythroid cells derived from human induced pluripotent stem cells.

Kai-Hsin Chang, Andy Huang, Roli K Hirata, Pei-Rong Wang, David W Russell, Thalia Papayannopoulou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20339107      PMCID： PMC2845905          DOI： 10.1182/blood-2009-11-252650

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

2.  Gene targeting of mutant COL1A2 alleles in mesenchymal stem cells from individuals with osteogenesis imperfecta.

Authors:  Joel R Chamberlain; David R Deyle; Ulrike Schwarze; Peirong Wang; Roli K Hirata; Yi Li; Peter H Byers; David W Russell
Journal:  Mol Ther       Date:  2007-10-23       Impact factor: 11.454

3.  Diverse hematopoietic potentials of five human embryonic stem cell lines.

Authors:  Kai-Hsin Chang; Angelique M Nelson; Paul A Fields; Jennifer L Hesson; Tatiana Ulyanova; Hua Cao; Betty Nakamoto; Carol B Ware; Thalia Papayannopoulou
Journal:  Exp Cell Res       Date:  2008-07-29       Impact factor: 3.905

4.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728

5.  Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin.

Authors:  Jacob Hanna; Marius Wernig; Styliani Markoulaki; Chiao-Wang Sun; Alexander Meissner; John P Cassady; Caroline Beard; Tobias Brambrink; Li-Chen Wu; Tim M Townes; Rudolf Jaenisch
Journal:  Science       Date:  2007-12-06       Impact factor: 47.728

6.  Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases.

Authors:  Lin Ye; Judy C Chang; Chin Lin; Xiaofang Sun; Jingwei Yu; Yuet Wai Kan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-29       Impact factor: 11.205

7.  Transduction of human embryonic stem cells by foamy virus vectors.

Authors:  Helen Gharwan; Roli K Hirata; Peirong Wang; Robert E Richard; Linlin Wang; Erik Olson; James Allen; Carol B Ware; David W Russell
Journal:  Mol Ther       Date:  2007-07-10       Impact factor: 11.454

8.  Hematopoietic development from human induced pluripotent stem cells.

Authors:  Claudia Lengerke; Matthias Grauer; Nina I Niebuhr; Tamara Riedt; Lothar Kanz; In-Hyun Park; George Q Daley
Journal:  Ann N Y Acad Sci       Date:  2009-09       Impact factor: 5.691

9.  Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders.

Authors:  Zhaohui Ye; Huichun Zhan; Prashant Mali; Sarah Dowey; Donna M Williams; Yoon-Young Jang; Chi V Dang; Jerry L Spivak; Alison R Moliterno; Linzhao Cheng
Journal:  Blood       Date:  2009-10-01       Impact factor: 22.113

10.  Hematopoietic and endothelial differentiation of human induced pluripotent stem cells.

Authors:  Kyung-Dal Choi; Junying Yu; Kim Smuga-Otto; Giorgia Salvagiotto; William Rehrauer; Maxim Vodyanik; James Thomson; Igor Slukvin
Journal:  Stem Cells       Date:  2009-03       Impact factor: 6.277
  10 in total
  27 in total

1.  Induced Pluripotent Stem Cells-A New Foundation in Medicine.

Authors:  George T-J Huang
Journal:  J Exp Clin Med       Date:  2010-10-22

2.  Reprogramming based gene therapy for inherited red blood cell disorders.

Authors:  Xiuling Xu; Jing Qu; Keiichiro Suzuki; Mo Li; Weizhou Zhang; Guang-Hui Liu; Juan Carlos Izpisua Belmonte
Journal:  Cell Res       Date:  2012-04-03       Impact factor: 25.617

Review 3.  Concise review: stem cell-derived erythrocytes as upcoming players in blood transfusion.

Authors:  Ann Zeuner; Fabrizio Martelli; Stefania Vaglio; Giulia Federici; Carolyn Whitsett; Anna Rita Migliaccio
Journal:  Stem Cells       Date:  2012-08       Impact factor: 6.277

4.  Transcriptional environment and chromatin architecture interplay dictates globin expression patterns of heterospecific hybrids derived from undifferentiated human embryonic stem cells or from their erythroid progeny.

Authors:  Kai-Hsin Chang; Andy Huang; Hemei Han; Yi Jiang; Xiangdong Fang; Chao-Zhong Song; Steve Padilla; Hao Wang; Hongzhu Qu; John Stamatoyannopoulos; Qiliang Li; Thalia Papayannopoulou
Journal:  Exp Hematol       Date:  2013-08-28       Impact factor: 3.084

Review 5.  Stem cell sources for vascular tissue engineering and regeneration.

Authors:  Vivek K Bajpai; Stelios T Andreadis
Journal:  Tissue Eng Part B Rev       Date:  2012-07-03       Impact factor: 6.389

6.  Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease.

Authors:  Jizhong Zou; Prashant Mali; Xiaosong Huang; Sarah N Dowey; Linzhao Cheng
Journal:  Blood       Date:  2011-08-31       Impact factor: 22.113

Review 7.  Reawakening fetal hemoglobin: prospects for new therapies for the β-globin disorders.

Authors:  Daniel E Bauer; Sophia C Kamran; Stuart H Orkin
Journal:  Blood       Date:  2012-08-17       Impact factor: 22.113

8.  Human induced pluripotent stem cells can reach complete terminal maturation: in vivo and in vitro evidence in the erythropoietic differentiation model.

Authors:  Ladan Kobari; Frank Yates; Noufissa Oudrhiri; Alain Francina; Laurent Kiger; Christelle Mazurier; Shaghayegh Rouzbeh; Wassim El-Nemer; Nicolas Hebert; Marie-Catherine Giarratana; Sabine François; Alain Chapel; Hélène Lapillonne; Dominique Luton; Annelise Bennaceur-Griscelli; Luc Douay
Journal:  Haematologica       Date:  2012-06-24       Impact factor: 9.941

9.  CD34+ cells from dental pulp stem cells with a ZFN-mediated and homology-driven repair-mediated locus-specific knock-in of an artificial β-globin gene.

Authors:  S Chattong; O Ruangwattanasuk; W Yindeedej; A Setpakdee; K Manotham
Journal:  Gene Ther       Date:  2017-05-22       Impact factor: 5.250

10.  Stem cell-derived erythrocytes as upcoming players in blood transfusion.

Authors:  A R Migliaccio
Journal:  ISBT Sci Ser       Date:  2013-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.